Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell membrane of oral bacteria, also called the cytoplasmic or plasma membrane, is a structurally distinct lipid bilayer embedded with diverse proteins that serves as a critical barrier, surrounding the cytoplasm and functioning in selective transport, energy transduction, and signal mediation[1][2][6]. It is primarily composed of phospholipids (forming a flexible, dynamic bilayer) and lacks cholesterol, which distinguishes it from eukaryotic membranes[2][6]. Integral and peripheral membrane proteins are involved in nutrient import, waste export, electron transport, ATP synthesis, and chemotaxis. The bacterial cell membrane is essential for survival, and its integrity is frequently targeted by specific antibiotics and antimicrobial agents, especially in oral infections and persistent biofilm-associated diseases[3][4][5]. Disrupting the bacterial membrane, by antibiotics or antiseptics, leads to cell death via leakage of intracellular components. Many antimicrobials, such as daptomycin and cationic peptides, act preferentially on bacterial membranes due to differences in lipid composition—offering a therapeutic window[3]. While not a "receptor" or enzyme in a classical sense, the bacterial cell membrane is considered a critical therapeutic target for eradication of oral pathogens and disrupting biofilms[3][8]. Note: - This target refers to a class of biological structure rather than a single defined molecule, which is not conventional for structured drug target information. - "Oral bacteria cell membrane" is non-specific and refers to the shared structure among diverse oral bacteria; the correct canonical form should be "Bacterial cell membrane (oral bacteria)," and it is not a conventional single-target molecule or receptor[3]. - There are many membrane proteins (receptors, transporters, enzymes) within this membrane that serve as more typical drug targets; if further specificity is needed (e.g., "membrane protein X in Streptococcus mutans"), please provide.
membrane disruption, depolarization, inhibition of membrane-bound ATP synthase, pore formation, increased permeability
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane (oral bacteria).